Literature DB >> 23800790

The EEG correlates of the TMS-induced EMG silent period in humans.

Faranak Farzan1, Mera S Barr, Sylco S Hoppenbrouwers, Paul B Fitzgerald, Robert Chen, Alvaro Pascual-Leone, Zafiris J Daskalakis.   

Abstract

Application of magnetic or electrical stimulation to the motor cortex can result in a period of electromyography (EMG) silence in a tonically active peripheral muscle. This period of EMG silence is referred to as the silent period (SP). The duration of SP shows intersubject variability and reflects the integrity of cortical and corticospinal pathways. A non-invasive technique for assessing the duration of SP is the combination of Transcranial Magnetic Stimulation (TMS) with EMG. Utilizing TMS-EMG, several studies have reported on the shortening or lengthening of SP in neuropsychiatric disorders such as schizophrenia, bipolar disorder, depression, obsessive compulsive disorder, epilepsy, Parkinson's disease, and stroke. However, cortical, corticospinal and peripheral components are difficult to disentangle from EMG alone. Here, we use the multimodal neuroimaging technique of TMS-EMG combined with concurrent electroencephalography (EEG) recording to further examine the cortical origin of SP and the cortical oscillatory activity that underlies SP genesis. We demonstrate that the duration of SP is related to the temporal characteristics of the cortical reactivity and the power of delta to alpha oscillations in both local and remote areas ipsilateral and contralateral to the stimulation site, and beta oscillations locally. We illustrate that, compared to EMG, the EEG indices of the SP provide additional information about the brain dynamics and propose that the EEG measures of SP may be used in future clinical and research investigations to more precisely delineate the mechanisms underlying inhibitory impairments.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cortical inhibition; Cortical oscillations; Electroencephalography; Electromyography; GABA; Motor cortex; Transcranial magnetic stimulation

Mesh:

Year:  2013        PMID: 23800790      PMCID: PMC4211432          DOI: 10.1016/j.neuroimage.2013.06.059

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  101 in total

1.  Interactions between two different inhibitory systems in the human motor cortex.

Authors:  T D Sanger; R R Garg; R Chen
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

2.  TMS-induced artifacts on EEG can be reduced by rearrangement of the electrode's lead wire before recording.

Authors:  Hirofumi Sekiguchi; Shigeki Takeuchi; Hiroshi Kadota; Yutaka Kohno; Yasoichi Nakajima
Journal:  Clin Neurophysiol       Date:  2011-05       Impact factor: 3.708

3.  Electroencephalographic recording during transcranial magnetic stimulation in humans and animals.

Authors:  John R Ives; Alexander Rotenberg; Roberto Poma; Gregor Thut; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2006-06-21       Impact factor: 3.708

4.  The effect of stimulus parameters on TMS-EEG muscle artifacts.

Authors:  Tuomas Mutanen; Hanna Mäki; Risto J Ilmoniemi
Journal:  Brain Stimul       Date:  2012-08-10       Impact factor: 8.955

5.  GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro.

Authors:  R A Deisz
Journal:  Neuropharmacology       Date:  1999-11       Impact factor: 5.250

6.  Transcranial magnetic stimulation-evoked inhibition of voluntary muscle activity (silent period) is impaired in patients with ischemic hemispheric lesion.

Authors:  H J Braune; C Fritz
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

7.  Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity.

Authors:  G Alagona; R Bella; R Ferri; A Carnemolla; A Pappalardo; E Costanzo; G Pennisi
Journal:  Neurosci Lett       Date:  2001-11-13       Impact factor: 3.046

8.  Cortical inhibition in attention deficit hyperactivity disorder: new insights from the electroencephalographic response to transcranial magnetic stimulation.

Authors:  Sarah Bruckmann; Daniela Hauk; Veit Roessner; Franz Resch; Christine M Freitag; Thomas Kammer; Ulf Ziemann; Aribert Rothenberger; Matthias Weisbrod; Stephan Bender
Journal:  Brain       Date:  2012-04-03       Impact factor: 13.501

9.  Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp.

Authors:  Nagako Murase; John C Rothwell; Ryuji Kaji; Ryo Urushihara; Kazumi Nakamura; Nobuki Murayama; Tomohiko Igasaki; Miyuki Sakata-Igasaki; Tatuya Mima; Akio Ikeda; Hiroshi Shibasaki
Journal:  Brain       Date:  2004-10-13       Impact factor: 13.501

10.  Transcranial magnetic stimulation in Clinical Pharmacology.

Authors:  Dimitrios Kapogiannis; Eric M Wassermann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008-12
View more
  40 in total

Review 1.  Locomotor activities as a way of inducing neuroplasticity: insights from conventional approaches and perspectives on eccentric exercises.

Authors:  Pierre Clos; Romuald Lepers; Yoann M Garnier
Journal:  Eur J Appl Physiol       Date:  2021-01-02       Impact factor: 3.078

Review 2.  Targeting the Cerebellum by Noninvasive Neurostimulation: a Review.

Authors:  Kim van Dun; Florian Bodranghien; Mario Manto; Peter Mariën
Journal:  Cerebellum       Date:  2017-06       Impact factor: 3.847

3.  Characterization of Glutamatergic and GABAA-Mediated Neurotransmission in Motor and Dorsolateral Prefrontal Cortex Using Paired-Pulse TMS-EEG.

Authors:  Robin F H Cash; Yoshihiro Noda; Reza Zomorrodi; Natasha Radhu; Faranak Farzan; Tarek K Rajji; Paul B Fitzgerald; Robert Chen; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

4.  A combined TMS-EEG study of short-latency afferent inhibition in the motor and dorsolateral prefrontal cortex.

Authors:  Yoshihiro Noda; Robin F H Cash; Reza Zomorrodi; Luis Garcia Dominguez; Faranak Farzan; Tarek K Rajji; Mera S Barr; Robert Chen; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J Neurophysiol       Date:  2016-05-25       Impact factor: 2.714

5.  Systematic examination of low-intensity ultrasound parameters on human motor cortex excitability and behavior.

Authors:  Anton Fomenko; Kai-Hsiang Stanley Chen; Jean-François Nankoo; James Saravanamuttu; Yanqiu Wang; Mazen El-Baba; Xue Xia; Shakthi Sanjana Seerala; Kullervo Hynynen; Andres M Lozano; Robert Chen
Journal:  Elife       Date:  2020-11-25       Impact factor: 8.140

6.  Impact of different intensities of intermittent theta burst stimulation on the cortical properties during TMS-EEG and working memory performance.

Authors:  Sung Wook Chung; Nigel C Rogasch; Kate E Hoy; Caley M Sullivan; Robin F H Cash; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2017-11-09       Impact factor: 5.038

7.  Abnormal EEG Responses to TMS During the Cortical Silent Period Are Associated With Hand Function in Chronic Stroke.

Authors:  Whitney A Gray; Jacqueline A Palmer; Steven L Wolf; Michael R Borich
Journal:  Neurorehabil Neural Repair       Date:  2017-06-12       Impact factor: 3.919

8.  Alleviation of ADHD symptoms by non-invasive right prefrontal stimulation is correlated with EEG activity.

Authors:  Uri Alyagon; Hamutal Shahar; Aviad Hadar; Noam Barnea-Ygael; Avi Lazarovits; Hadar Shalev; Abraham Zangen
Journal:  Neuroimage Clin       Date:  2020-02-06       Impact factor: 4.881

9.  TMS evoked N100 reflects local GABA and glutamate balance.

Authors:  Xiaoming Du; Laura M Rowland; Ann Summerfelt; Andrea Wijtenburg; Joshua Chiappelli; Krista Wisner; Peter Kochunov; Fow-Sen Choa; L Elliot Hong
Journal:  Brain Stimul       Date:  2018-05-04       Impact factor: 8.955

10.  The effects of individualised intermittent theta burst stimulation in the prefrontal cortex: A TMS-EEG study.

Authors:  Sung Wook Chung; Caley M Sullivan; Nigel C Rogasch; Kate E Hoy; Neil W Bailey; Robin F H Cash; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2018-09-25       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.